PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
35.71%
Net income growth above 1.5x VUZI's 11.25%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-17.24%
Negative yoy D&A while VUZI is 22.92%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
71.43%
Deferred tax of 71.43% while VUZI is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
600.00%
SBC growth while VUZI is negative at -72.80%. John Neff would see competitor possibly controlling share issuance more tightly.
-142.31%
Both reduce yoy usage, with VUZI at -19.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-1620.00%
Both yoy AR lines negative, with VUZI at -73.35%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-139.42%
Both negative yoy AP, with VUZI at -192.98%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
50.00%
Lower 'other working capital' growth vs. VUZI's 352.14%. David Dodd would see fewer unexpected short-term demands on cash.
50.00%
Lower 'other non-cash' growth vs. VUZI's 100.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-91.84%
Both yoy CFO lines are negative, with VUZI at -38.64%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-15.00%
Both yoy lines negative, with VUZI at -18.60%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-108.98%
Negative yoy purchasing while VUZI stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-14.56%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
200.00%
Growth well above VUZI's 6.90%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-89.38%
Both yoy lines negative, with VUZI at -13.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
400.00%
Stock issuance far above VUZI's 124.06%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.